Tenax Therapeutics, Inc. · NASDAQ:TENX
Ikarian Capital, LLC's stake in Tenax Therapeutics, Inc. fell to 2.90% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Ikarian Capital, LLC's stake in Tenax Therapeutics, Inc. fell to 2.90%, 1,080,700 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 2.90%
- Shares
- 1,080,700
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ikarian Capital, LLC | 2.90% | 1,080,700 |
| Neil Shahrestani | 2.90% | 1,080,700 |
Source
Related
- Tenax Therapeutics, Inc.
- Ikarian Capital, LLC
- Tenax Therapeutics, Inc. shareholders
- Schedule 13G/A · Ikarian Capital, LLC · Apr 7, 2026
- Schedule 13G/A · Ikarian Capital, LLC · Dec 5, 2025
- Schedule 13G · Ikarian Capital, LLC · Oct 7, 2025
- Form 4 · ADAR1 Capital Management, LLC · Oct 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026